OTC · Biotechnology

Living Cell Technologies Limited (LVCLY) Stock

$0.03 +24.39% OTC: LVCLY Healthcare

Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand.

Valuation

MetricValue
Price$0.03
Market Cap$11.39M
P/E Ratio-11.54
P/B Ratio8.03
P/S Ratio195.96
EPS (TTM)$-0.01
52-Week High$0.08
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-61.85%
ROA-65.64%
ROCE-68.93%
Gross Margin100.00%
Operating Margin—
Net Margin—
Debt/Equity0.00
Current Ratio17.89

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-2.0M$-2.0M$-2.0M$-2.0M
Net Profit$-1.0M$-1.0M$-2.0M$-2.0M$-2.0M
EPS$-0.02$-0.02$-0.02$-0.02$-0.01
Op Margin-99304.0%-849.7%-69781.2%-5068.3%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$3.0M$2.0M$4.0M$4.0M$3.0M
Total Liabilities$1.0M$0$0$0$0
Cash$3.0M$2.0M$4.0M$4.0M$3.0M
Borrowings$0$0$0$0$0

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-3.0M$-1.0M$-2.0M$-2.0M$-2.0M
Investing Cash Flow$2.0M$0$0$0$0
Financing Cash Flow$0$0$5.0M$2.0M$1.0M
Net Cash Flow$-2.0M$-1.0M$3.0M$0$0
Free Cash Flow$-3.0M$-1.0M$-2.0M$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA-13.57
FCF Yield-6.21%
Quick Ratio17.89
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATBPFAntibe Therapeutics Inc. $0.22 -0.19% -0.80 $11.43M 0.00%
AVEFFAvecho Biotechnology Limited $0.00 — -15.71 $13.35M 0.00%
BNOEFBionomics Limited $0.01 -14.89% -0.30 $8.81M 0.00%
CRPOFCeapro Inc. $0.17 -13.04% -3.74 $13.31M 0.00%
EIGRQEiger BioPharmaceuticals, Inc. $8.50 +6.25% -0.17 $12.59M 0.00%

About Living Cell Technologies Limited

Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand. A primary focus for LCT is NTCELL, a novel alginate-coated capsule currently progressing through Phase IIb clinical trials for its application in treating Parkinson's disease. The company was founded in 1987 and operates from its base in Sydney, Australia.

Living Cell Technologies Limited is headquartered in AU.

Living Cell Technologies Limited (LVCLY) stock trades at $0.03 with a market capitalization of $11.39M. The stock is valued at a price-to-earnings (P/E) ratio of -11.54, price-to-book of 8.03, price-to-sales of 195.96. Over the past 52 weeks the stock has ranged between $0.02 and $0.08, and currently trades 62.5% below its 52-week high.

On profitability, Living Cell Technologies Limited generates a return on equity (ROE) of -61.85%, return on capital employed of -68.93%.

Official website: www.lctglobal.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides